Diametric Capital’s Medicines Co MDCO Stock Holding History

Diametric Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,382	Closed	-$719K	–	160
2019 Q3	$719K	Buy	+14,382	New	+$574K	0.59%	57

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Diametric Capital's MDCO Position: Q4 2019 in Review

Diametric Capital sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 14,382 shares — an estimated $719K sold.

Diametric Capital first reported a position in MDCO in Q3 2019 and held it in 1 quarter. The position peaked at $719K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Diametric Capital reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Diametric Capital sold 14,382 Medicines Co shares in Q4 2019, an estimated $719K.
Diametric Capital first reported a position in Medicines Co in Q3 2019 and held it in 1 quarter.
Diametric Capital's Medicines Co position peaked at $719K in Q3 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Diametric Capital's 13F filing for Q4 2019, filed 14 Feb 2020.